Ibnsina Pharma (EGX:ISPH)
Egypt
· Delayed Price · Currency is EGP 11.09
-0.08 (-0.72%)
At close: Apr 28, 2026
Ibnsina Pharma Revenue
In the year 2025, Ibnsina Pharma had annual revenue of 76.60B EGP with 37.17% growth. Ibnsina Pharma had revenue of 21.20B in the quarter ending December 31, 2025, with 21.57% growth.
Revenue
76.60B
Revenue Growth
+37.17%
P/S Ratio
0.15
Revenue / Employee
13.93M
Employees
5,500
Market Cap
11.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76.60B | 20.75B | 37.17% |
| Dec 31, 2024 | 55.84B | 21.89B | 64.49% |
| Dec 31, 2023 | 33.95B | 11.68B | 52.48% |
| Dec 31, 2022 | 22.26B | 531.66M | 2.45% |
| Dec 31, 2021 | 21.73B | 3.05B | 16.35% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cairo For Investment And Real Estate Developments-CIRA Education | 4.77B |
| Taaleem Management Services Company S.A.E. | 2.23B |
| CI Capital Holding For Financial Investments (S.A.E) | 4.51B |
| Misr Hotels Company | 1.98B |
| Maridive and Oil Services S.A.E. | 11.54B |
| Alexandria Mineral Oils Company | 40.11B |
| Egyptian Gulf Bank (S.A.E) | 10.76B |
| Misr National Steel - Ataqa | 6.33B |